Quantum Genomics announces the end of its collaboration with Chinese Pharma Qilu
PARIS: Quantum Genomics announced the end of its collaboration with Chinese Pharma Qilu in the development and the commercialization of firibastat in China. Quantum Genomics is a biopharmaceutical company specializing in developing a new drug class that directly targets the…